tiprankstipranks
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
US Market

Pasithea Therapeutics Corp (KTTA) Income Statement

Compare
49 Followers

Pasithea Therapeutics Corp Income Statement

Last quarter (Q3 2024), Pasithea Therapeutics Corp's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pasithea Therapeutics Corp's net income was $-3.00M. See Pasithea Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 486.56K$ 15.06K$ 0.00
Gross Profit
$ -648.45K$ 373.36K$ -2.21K$ 0.00
Operating Expenses
$ 15.98M$ 15.19M$ 4.51M$ 40.98K
Depreciation and Amortization
$ 648.45K$ 5.09K$ 1.38K$ 61.48K
EBITDA
$ -15.33M$ -12.58M$ -4.51M$ 0.00
Operating Income
$ -15.98M$ -14.82M$ -4.51M$ -40.98K
Other Income/Expenses
$ 471.61K$ 861.09K$ 2.33M$ -4.00
Pretax Income
$ -15.51M$ -13.94M$ -2.17M$ -40.98K
Net Income
$ -15.96M$ -13.06M$ -2.17M$ -40.98K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -12.65$ -10.34$ -1.89$ -0.06
Diluted EPS
$ -13.01$ -10.34$ -1.89$ -0.06
Weighted Average Shares Outstanding
1.26M 1.26M 1.15M 688.92K
Weighted Average Shares Outstanding (Diluted)
1.23M 1.26M 1.15M 688.92K
Currency in USD

Pasithea Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis